707
Views
2
CrossRef citations to date
0
Altmetric
Influenza

Determinants of compliance to influenza and COVID-19 vaccination in a cohort of solid organ transplant patients in Puglia, Southern Italy (2017–2022)

, , , , , , , & ORCID Icon show all
Article: 2266932 | Received 30 Jul 2023, Accepted 30 Sep 2023, Published online: 16 Oct 2023

References

  • Lee I, Barton TD. Viral respiratory tract infections in transplant patients: epidemiology, recognition and management. Drugs. 2007;67(10):1411–8. doi:10.2165/00003495-200767100-00004.
  • Weigt SS, Gregson AL, Deng JC, Lynch J, Belperio J. Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients. Semin Respir Crit Care Med. 2011;32(4):471–93. doi:10.1055/s-0031-1283286.
  • Mombelli M, Lang BM, Neofytos D, Aubert J-D, Benden C, Berger C, Boggian K, Egli A, Soccal PM, Kaiser L, et al. Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study. Am J Transplant. 2021;21(5):1789–800. doi:10.1111/ajt.16383.
  • Martin ST, Torabi MJ, Gabardi S. Influenza in solid organ transplant recipients. Ann Pharmacother. 2012;46(2):255–64. doi:10.1345/aph.1Q436.
  • Gatti M, Rinaldi M, Bussini L, Bonazzetti C, Pascale R, Pasquini Z, Faní F, Pinho Guedes MN, Azzini AM, Carrara E, et al. Clinical outcome in solid organ transplant recipients affected by COVID-19 compared to general population: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(8):1057–65. doi:10.1016/j.cmi.2022.02.039.
  • Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and solid organ transplantation: a review article. Transplantation. 2021;105(1):37–55. doi:10.1097/TP.0000000000003523.
  • Danziger-Isakov L, Blumberg EA, Manuel O, Sester M. Impact of COVID-19 in solid organ transplant recipients. Am J Transplant. 2021;21(3):925–37. doi:10.1111/ajt.16449.
  • Gallone MS, Infantino V, Ferorelli D, Stefanizzi P, De Nitto S, Tafuri S. Vaccination coverage in patients affected by chronic diseases: a 2014 cross-sectional study among subjects hospitalized at Bari Policlinico General Hospital. Am J Infect Control. 2018 Jan;46(1):e9–e11. doi:10.1016/j.ajic.2017.10.004.
  • Stefanizzi P, De Nitto S, Spinelli G, Lattanzio S, Stella P, Ancona D, Dell’aera M, Padovano M, Soldano S, Tafuri S, et al. Post-marketing active surveillance of adverse reactions following influenza cell-based quadrivalent vaccine: an Italian prospective observational study. Vaccines. 2021;9(5):456. doi:10.3390/vaccines9050456.
  • Harboe ZB, Modin D, Gustafsson F, Perch M, Gislason G, Sørensen SS, Rasmussen A, Biering-Sørensen T, Nielsen SD. Effect of influenza vaccination in solid organ transplant recipients: a nationwide population-based cohort study. Am J Transplant. 2022 Oct;22(10):2409–17. Epub 2022 May 16. PMID: 35384275; PMCID: PMC9790571. doi:10.1111/ajt.17055.
  • Negahdaripour M, Shafiekhani M, Moezzi SMI, Amiri S, Rasekh S, Bagheri A, Mosaddeghi P, Vazin A. Administration of COVID-19 vaccines in immunocompromised patients. Int Immunopharmacol. 2021;99:108021. doi:10.1016/j.intimp.2021.108021.
  • Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, Beyer WEP, Tilanus HW, Kemmeren MH, Metselaar HJ, de Man RA, Osterhaus ADME. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol. 2000;61(1):85–93. doi:10.1002/(SICI)1096-9071(200005)61:1<85:AID-JMV14>3.0.CO;2-H.
  • Boyarsky BJ, Werbel WA, Avery RK, Tobian AAR, Massie AB, Segev DL, Garonzik-Wang JM. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325(21):2204–6. doi:10.1001/jama.2021.7489.
  • Repubblica Italiana. Conferenza permanente per i rapporti tra lo stato le regioni e le province autonome di Trento e Bolzano. Intesa, ai sensi dell’articolo 8, comma 6, della legge 5 giugno 2003, n. 131, tra il Governo, le regioni e le province autonome di Trento e Bolzano sul documento recante “Piano nazionale prevenzione vaccinale 2017-2019” (Rep. atti n. 10/CSR) (17A01195). Intesa 19 gennaio 2017. Italian Republic’s Official Gazette, n. 41. Rome. February 18, 2017.
  • Repubblica Italiana. Ministero della Salute, Direzione Generale della Prevenzione Sanitaria. Nota n. 41416 del 14 settembre 2021, ad oggetto “Indicazioni preliminari sulla somministrazione di dosi addizionali e di dosi “booster” nell’ambito della campagna di vaccinazione anti-SARS-CoV-2/COVID-19. Rome. September 14, 2021.
  • Venerito V, Stefanizzi P, Fornaro M, Cacciapaglia F, Tafuri S, Perniola S, Iannone F, Lopalco G. Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors. RMD Open. 2022 Jan;8(1):e001847. doi:10.1136/rmdopen-2021-001847.
  • Dib M, Le Corre N, Ortiz C, García D, Ferrés M, Martinez-Valdebenito C, Ruiz-Tagle C, Ojeda MJ, Espinoza MA, Jara A, et al. SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: a prospective cohort study. Lancet Reg Health Am. 2022 Dec;16:100371 . Epub 2022 Sep 23. doi:10.1016/j.lana.2022.100371.
  • Malinis M, Cohen E, Azar MM. Effectiveness of SARS-CoV-2 vaccination in fully vaccinated solid organ transplant recipients. Am J Transplant. 2021 Aug;21(8):2916–8. Epub 2021 Jul 10. doi:10.1111/ajt.16713.
  • Harris K, Baggs J, Davis RL, Black S, Jackson LA, Mullooly JP, Chapman LE. Influenza vaccination coverage among adult solid organ transplant recipients at three health maintenance organizations, 1995–2005. Vaccine. 2009;27(17):2335–41. doi:10.1016/j.vaccine.2009.02.026.
  • Istituto Superiore di Sanità (Italian High Institute for Healthcare). Sorveglianza PASSI (PASSI project surveillance). Influenza vaccination. 2023 June 30. https://www.epicentro.iss.it/passi/dati/VaccinazioneAntinfluenzale.
  • Italian Republic. Legge 16 settembre 2021, n. 126. Conversione in legge, con modificazioni, del decreto-legge 23 luglio 2021, n. 105, recante misure urgenti per fronteggiare l’emergenza epidemiologica da COVID-19 e per l’esercizio in sicurezza di attività sociali ed economiche. (21G00136). Italian Republic’s Official Gazette, n. 224. Rome. September 16, 2021.
  • Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP, Marques ETA. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl Trop Dis. 2020;14(12):e0008961. Published 2020 Dec 17. doi: 10.1371/journal.pntd.0008961.
  • Dugord C, Franc C. Trajectories and individual determinants of repeated seasonal flu vaccination use over the long term using data from the French E3N cohort. Vaccine. 2022;40(34):5030–43. doi:10.1016/j.vaccine.2022.07.004.
  • Han K, Francis MR, Xia A, Zhang R, Hou Z. Influenza vaccination uptake and its determinants during the 2019-2020 and early 2020-2021 flu seasons among migrants in Shanghai, China: a cross-sectional survey. Hum Vaccin Immunother. 2022;18(1):1–8. doi:10.1080/21645515.2021.2016006.
  • Larsen L, Bistrup C, Sørensen SS, Boesby L, Nguyen MTT, Johansen IS. The coverage of influenza and pneumococcal vaccination among kidney transplant recipients and waiting list patients: a cross-sectional survey in Denmark. Transpl Infect Dis. 2021;23(3):e13537. doi:10.1111/tid.13537.
  • Boey L, Bosmans E, Ferreira LB, Heyvaert N, Nelen M, Smans L, Tuerlinckx H, Roelants M, Claes K, Derdelinckx I, et al. Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups. Hum Vaccin Immunother. 2020;16(9):2136–43. doi:10.1080/21645515.2020.1763739.
  • Khomane P, Meshram HS, Banerjee S, Tambi P, Patel H, Patel A, Makwana MJ, Sharma S, Mishra V, Kute VB, et al. COVID-19 vaccination in solid-organ transplant: a real-world multicenter experience. Exp Clin Transplant. 2022;20(9):805–10. doi:10.6002/ect.2022.0090.
  • Zheng Z, Lu Y, Wang M, Luo Y, Wan P, Zhou T, Feng M, Zhu J, Wu J, Ji H, et al. Low COVID-19 vaccine coverage and guardian acceptance among pediatric transplant recipients. J Med Virol. 2023;95(1):e28377. doi:10.1002/jmv.28377.
  • Stefanizzi P, Provenzano S, Santangelo OE, Dallagiacoma G, Gianfredi V. Past and future influenza vaccine uptake motivation: a cross-sectional Analysis among Italian Health sciences students. Vaccines. 2023;11(4):717. doi:10.3390/vaccines11040717.
  • Tomietto M, Simonetti V, Comparcini D, Stefanizzi P, Cicolini G. A large cross-sectional survey of COVID-19 vaccination willingness amongst healthcare students and professionals: reveals generational patterns. J Adv Nurs. 2022 Sep;78(9):2894–903. Epub 2022 Mar 17. PMID: 35301774; PMCID: PMC9111790. doi:10.1111/jan.15222.
  • Kowalik M. Ethics of vaccine refusal. J Med Ethics. 2022;48(4):240–3. doi:10.1136/medethics-2020-107026.
  • Chon WJ, Kadambi PV, Harland RC, Thistlethwaite JR, West BL, Udani S, Poduval R, Josephson MA. Changing attitudes toward influenza vaccination in U.S. Kidney transplant programs over the past decade. Clin J Am Soc Nephrol. 2010;5(9):1637–41. doi:10.2215/CJN.00150110.
  • Lang P, Wu CT, Le-Nguyen AF, Czock A. Influenza vaccination behaviour of healthcare workers in Switzerland: a cross-sectional study. Int J Public Health. 2023;68:1605175. Published 2023 Mar 10. doi:10.3389/ijph.2023.1605175.
  • Hippen BE, Axelrod DA, Maher K, Li R, Kumar D, Caliskan Y, Alhamad T, Schnitzler M, Lentine KL. Survey of current transplant center practices regarding COVID-19 vaccine mandates in the United States. Am J Transplant. 2022;22(6):1705–13. doi:10.1111/ajt.16995.
  • Di Gennaro F, Murri R, Segala FV, Cerruti L, Abdulle A, Saracino A, Bavaro DF, Fantoni M. Attitudes towards anti-SARS-CoV2 vaccination among healthcare workers: results from a national survey in Italy. Viruses. 2021;13(3):371. Published 2021 Feb 26. doi: 10.3390/v13030371.
  • Bianchi FP, Tafuri S, Migliore G, Vimercati L, Martinelli A, Lobifaro A, Diella G, Stefanizzi P, on behalf of the Control Room Working Group. BNT162b2 mRNA COVID-19 vaccine effectiveness in the prevention of SARS-CoV-2 infection and symptomatic disease in five-month follow-up: a retrospective cohort study. Vaccines. 2021;9(10):1143. doi:10.3390/vaccines9101143.
  • Lin DY, Gu Y, Wheeler B, Young H, Holloway S, Sunny SK, Moore Z, Zeng D. Effectiveness of covid-19 vaccines over a 9-month period in North Carolina. N Engl J Med. 2022 Mar 10;386(10):933–41. Epub 2022 Jan 12. PMID: 35020982; PMCID: PMC8781317. doi:10.1056/NEJMoa2117128.
  • Porru S, Monaco MGL, Spiteri G, Carta A, Pezzani MD, Lippi G, Gibellini D, Tacconelli E, Dalla Vecchia I, Sala E, et al. SARS-CoV-2 breakthrough infections: incidence and risk factors in a large European multicentric cohort of Health workers. Vaccines. 2022;10(8):1193. doi:10.3390/vaccines10081193.
  • Gesser-Edelsburg A, Badarna Keywan H. Physicians’ perspective on vaccine-hesitancy at the beginning of Israel’s COVID-19 vaccination campaign and Public’s perceptions of physicians’ knowledge When recommending the vaccine to their patients: a cross-sectional study. Front Public Health. 2022 Mar 10;10:855468. PMID: 35356022; PMCID: PMC8960033. doi:10.3389/fpubh.2022.855468.
  • Pan Y, Gong S, Zhu X, Xue C, Jing Y, Sun Y, Qian Y, Zhang J, Xia Q. Investigation on the hesitancy of COVID-19 vaccination among liver transplant recipients: a cross-sectional study in China. Front Public Health. 2022;10:1014942. Published 2022 Dec 15. doi:10.3389/fpubh.2022.1014942.
  • Ou MT, Boyarsky BJ, Zeiser LB, Po-Yu Chiang T, Ruddy J, Van Pilsum Rasmussen SE, Martin J, St. Clair Russell J, Durand CM, Avery RK, et al. Kidney transplant recipient attitudes toward a SARS-CoV-2 vaccine. Transplant Direct. 2021;7(7):e713. Published 2021 Jun 10. doi:10.1097/TXD.0000000000001171.
  • Restivo V, Vizzini G, Mularoni A, Di Benedetto C, Gioè SM, Vitale F. Determinants of influenza vaccination among solid organ transplant recipients attending sicilian reference center. Hum Vaccin Immunother. 2017;13(2):346–50. doi:10.1080/21645515.2017.1264792.
  • Tafuri S, Fortunato F, Gallone MS, Stefanizzi P, Calabrese G, Boccalini S, Martinelli D, Prato R. Systematic causality assessment of adverse events following HPV vaccines: analysis of current data from Apulia region (Italy). Vaccine. 2018 Feb 14;36(8):1072–7. Epub 2018 Jan 19. PMID: 29358055. doi:10.1016/j.vaccine.2018.01.018.
  • Stefanizzi P, Bianchi FP, Spinelli G, Amoruso F, Ancona D, Stella P, Tafuri S. Postmarketing surveillance of adverse events following meningococcal B vaccination: data from Apulia region, 2014-19. Hum Vaccin Immunother. 2022 Dec 31;18(1):1–6. Epub 2021 Aug 26. PMID: 34435938; PMCID: PMC8920168. doi:10.1080/21645515.2021.2011652.
  • Ajlan AA, Ali T, Aleid H, Almeshari K, DeVol E, Alkaff MA, Fajji L, Alali A, Halabi D, Althuwaidi S, et al. Comparison of the safety and immunogenicity of the BNT-162b2 vaccine and the ChAdOx1 vaccine for solid organ transplant recipients: a prospective study. BMC Infect Dis. 2022;22(1):786. doi:10.1186/s12879-022-07764-x.
  • Grupper A, Katchman H. SARS-CoV-2 vaccines: safety and immunogenicity in solid organ transplant recipients and strategies for improving vaccine responses. Curr Transpl Rep. 2022;9(1):35–47. Epub 2022 Jan 22. PMID: 35096509; PMCID: PMC8783189. doi: 10.1007/s40472-022-00359-0.
  • World Health Organization. Interim statement on booster doses for COVID-19 vaccination. 2021 October 4. https://www.who.int/news/item/04-10-2021-interim-statement-on-booster-doses-for-covid-19-vaccination
  • Circolare del Ministero della Salute n25782 del 14 agosto 2023 - Indicazioni preliminari per la campagna di vaccinazione autunnale e invernale anti COVID-19. https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2023&codLeg=95893&parte=1%20&serie=null
  • Stefanizzi P, Martinelli A, Bianchi FP, Migliore G, Tafuri S. Acceptability of the third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: preliminary data in a sample of Italian HCWs. Hum Vaccin Immunother. 2022 Dec 31;18(1):1–2. Epub 2021 Dec 10. doi:10.1080/21645515.2021.2011652.
  • Moscara L, Venerito V, Martinelli A, Di Lorenzo A, Toro F, Violante F, Tafuri S, Stefanizzi P. Safety profile and SARS-CoV-2 breakthrough infections among HCWs receiving anti-SARS-CoV-2 and influenza vaccines simultaneously: an Italian observational study. Vaccine. 2023 Aug 31;41(38):5655–61. Epub 2023 Aug 4. doi:10.1016/j.vaccine.2023.07.043.
  • Felzer JR, Finney Rutten LJ, Wi CI, LeMahieu AM, Beam E, Juhn YJ, Jacobson RM, Kennedy CC. Disparities in vaccination rates in solid organ transplant patients. Transpl Infect Dis. 2023;25(2):e14010. doi:10.1111/tid.14010.
  • Trucchi C, Costantino C, Restivo V, Bertoncello C, Fortunato F, Tafuri S, Amicizia D, Martinelli D, Paganino C, Piazza MF, et al. Immunization campaigns and strategies against human papillomavirus in Italy: the results of a survey to regional and local Health units representatives. Biomed Res Int. 2019 Jul 4;2019:6764154. PMID: 31355274; PMCID: PMC6637711. doi:10.1155/2019/6764154.
  • Takagi MA, Hess S, Smith Z, Gawronski K, Kumar A, Horsley J, Haddad N, Noveloso B, Zyzanski S, Ragina N. The impact of educational interventions on COVID-19 and vaccination attitudes among patients in Michigan: a prospective study. Front Public Health. 2023 Apr 3;11:1144659. PMID: 37077191; PMCID: PMC10106744. doi:10.3389/fpubh.2023.1144659.